ATE489971T1 - Ionaustausch-tumor zielausrichtung - Google Patents

Ionaustausch-tumor zielausrichtung

Info

Publication number: ATE489971T1
Authority: AT; Austria
Prior art keywords: ion exchange; tumor targeting; tumor; compound; intratumoral
Prior art date: 1998-10-13

Application number

AT99970330T

Other languages

English (en)

Inventor

Anders Holmberg

Original Assignee

Dextech Medical Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-13

Filing date

1999-10-12

Publication date

2010-12-15

1999-10-12 Application filed by Dextech Medical Ab filed Critical Dextech Medical Ab

2010-12-15 Application granted granted Critical

2010-12-15 Publication of ATE489971T1 publication Critical patent/ATE489971T1/de

Links

206010028980 Neoplasm Diseases 0.000 title abstract 3
230000008685 targeting Effects 0.000 title abstract 2
238000005342 ion exchange Methods 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
229920002307 Dextran Polymers 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
125000000524 functional group Chemical group 0.000 abstract 1
238000003384 imaging method Methods 0.000 abstract 1
230000002601 intratumoral effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
- A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Optics & Photonics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Physics & Mathematics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT99970330T 1998-10-13 1999-10-12 Ionaustausch-tumor zielausrichtung ATE489971T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9803482A SE9803482D0 (sv)	1998-10-13	1998-10-13	Ion exchange tumor targeting (IETT)
PCT/SE1999/001837 WO2000021571A1 (en)	1998-10-13	1999-10-12	Ion exchange tumor targeting (iett)

Publications (1)

Publication Number	Publication Date
ATE489971T1 true ATE489971T1 (de)	2010-12-15

Family

ID=20412924

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99970330T ATE489971T1 (de)	1998-10-13	1999-10-12	Ionaustausch-tumor zielausrichtung

Country Status (11)

Country	Link
US (1)	US6569841B1 (de)
EP (1)	EP1137441B1 (de)
JP (1)	JP2002527407A (de)
AT (1)	ATE489971T1 (de)
AU (1)	AU759251B2 (de)
CA (1)	CA2347424C (de)
DE (1)	DE69943003D1 (de)
IL (1)	IL142292A0 (de)
NO (1)	NO20011817D0 (de)
SE (1)	SE9803482D0 (de)
WO (1)	WO2000021571A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI20010764A0 (fi) *	2001-04-11	2001-04-11	Map Medical Technologies Oy	Kationiset dekstraanijohdannaiset käytettäväksi munuaisten suojaamiseen
US8377484B1 (en)	2004-05-06	2013-02-19	Maria V. Tsiper	Tumor encapsulation for prevention and treatment of metastatic cancer disease
CN101460523A (zh) *	2006-04-07	2009-06-17	阿道恰公司	双官能化多糖
FI119513B (fi) *	2007-03-07	2008-12-15	Dextech Medical Ab	Muokatut hydroksipolymeerikonjugaatit, joilla on tappava vaikutus tuumorisoluihin
FR2919189A1 (fr) *	2007-07-26	2009-01-30	Cyclopharma Sa Lab	Nouvelles compositions a base de polyosides greffes par des composes polyamines ou polysoufres.
US7998368B2 (en) *	2007-11-26	2011-08-16	United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration	Aqueous solution dispersement of carbon nanotubes
US20110118207A1 (en) *	2008-04-07	2011-05-19	Dextech Medical Ab	Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
KR101450838B1 (ko)	2012-02-08	2014-10-15	가톨릭대학교 산학협력단	표적화 화학요법을 위한 암 인식 지능형 폴리펩티드 및 이의 제조방법
DE102014016901B4 (de) *	2014-09-17	2021-08-12	Friedrich-Schiller-Universität Jena	Verfahren zur Herstellung für neue Dextranderivate als Wirkstoffträgersystem und deren Verwendung
FI127538B (en)	2016-06-22	2018-08-31	Dextech Medical Ab	MODIFIED Dextran Conjugates
PL240772B1 (pl) *	2018-06-11	2022-06-06	Nanothea Spolka Akcyjna	Sposób wytwarzania nanocząstek polimerowych chelatujących izotopy promieniotwórcze do zastosowania w diagnostyce i terapii

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5051257A (en) *	1989-05-09	1991-09-24	Pietronigro Dennis D	Antineoplastic solution and method for treating neoplasms

1998
- 1998-10-13 SE SE9803482A patent/SE9803482D0/xx unknown
1999
- 1999-10-12 WO PCT/SE1999/001837 patent/WO2000021571A1/en not_active Ceased
- 1999-10-12 DE DE69943003T patent/DE69943003D1/de not_active Expired - Lifetime
- 1999-10-12 JP JP2000575543A patent/JP2002527407A/ja active Pending
- 1999-10-12 AU AU14247/00A patent/AU759251B2/en not_active Expired
- 1999-10-12 EP EP99970330A patent/EP1137441B1/de not_active Expired - Lifetime
- 1999-10-12 US US09/807,542 patent/US6569841B1/en not_active Expired - Lifetime
- 1999-10-12 AT AT99970330T patent/ATE489971T1/de not_active IP Right Cessation
- 1999-10-12 CA CA002347424A patent/CA2347424C/en not_active Expired - Lifetime
- 1999-10-12 IL IL14229299A patent/IL142292A0/xx unknown
2001
- 2001-04-10 NO NO20011817A patent/NO20011817D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1137441B1 (de)	2010-12-01
DE69943003D1 (de)	2011-01-13
US6569841B1 (en)	2003-05-27
IL142292A0 (en)	2002-03-10
NO20011817L (no)	2001-04-10
CA2347424C (en)	2009-12-08
AU1424700A (en)	2000-05-01
SE9803482D0 (sv)	1998-10-13
WO2000021571A1 (en)	2000-04-20
AU759251B2 (en)	2003-04-10
EP1137441A1 (de)	2001-10-04
JP2002527407A (ja)	2002-08-27
NO20011817D0 (no)	2001-04-10
CA2347424A1 (en)	2000-04-20

Similar Documents

Publication	Publication Date	Title
CY1109881T1 (el)	2014-09-10	Νεοαγγειακα-συγκεκριμενα πεπτιδια
ATE285798T1 (de)	2005-01-15	Radioaktive embolisierende zusammensetzungen
ES2141128T3 (es)	2000-03-16	Combinacion de agentes anti-hormonales y moleculas de fijacion.
SE9803482D0 (sv)	1998-10-13	Ion exchange tumor targeting (IETT)
BR0306715A (pt)	2004-12-28	Métodos para diagnóstico e tratamento de tumores
BR9710646A (pt)	2000-01-11	Pródrogas de paclitaxel solúveis em água.
WO2004111192A3 (en)	2005-06-16	Targeted delivery to legumain-expressing cells
DE60224816D1 (de)	2008-03-13	Subzelluläres targeting von therapeutischen proteinen
BR9808881A (pt)	2001-09-11	Compostos para imunoterapia de câncer de próstata e métodos para seu uso
ATE365562T1 (de)	2007-07-15	Zielgerichtete kombinations-immuntherapie für krebs
AU4932199A (en)	2000-02-21	Cancer antigens based on tumor suppressor gene wt1 product
WO2003072125A8 (en)	2004-03-11	Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides
BG103091A (en)	2000-05-31	Shortened soluble receptors of type i & ii of the tumour necrotizing factor
TR199901949T2 (xx)	2000-01-21	Lemfositik t�m�rler i�in �areler.
BR0010590A (pt)	2003-07-22	Emprego de filanto para estimulação objetivada do sistema imunológico
ATE316134T1 (de)	2006-02-15	Zusammensetzung mit alpha-glycosylceramid zur stärkung zellulärer immunogenität
DE60039730D1 (de)	2008-09-11	Genetisch manipulierte Herpesviren zur Behandlung von Tumoren
BR0208017A (pt)	2004-12-07	Combinação compreendendo combretastatina e agentes anticâncer
WO2004110255A3 (en)	2005-10-27	Antineoplastic agents targeted via glut transporters
PL342614A1 (en)	2001-06-18	Anticarcinogenic drugs
WO1999002704A3 (en)	1999-04-01	Dual specifically phosphatase and methods of use
WO2005007079A3 (en)	2005-05-19	Inactivators and bivalent inhibitors of glyoxalase i and methods of inhibiting tumor growth
WO2000040752A3 (en)	2000-11-23	Cancer associated genes and their products
AU5992500A (en)	2001-01-31	Compound derived from an offset orf of the ice gene
BR0207327A (pt)	2004-02-10	Amino derivados de biotina e seus conjugados com agentes quelantes macrocìclicos

Legal Events

Date	Code	Title	Description
2011-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties